Applied Biosystems / MDS Sciex Launches New Line Of Chromatography Systems For Biomarker, Drug Discovery, And Proteomics Studies

FOSTER CITY, Calif. & TORONTO--(BUSINESS WIRE)--Nov. 16, 2005-- Nano, Micro and MALDI HPLC Systems Provide Complete Single Vendor Solution for Mass Spectrometry-Based Applications Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, together with its joint venture partner MDS Sciex, a division of MDS Inc. (NYSE:MDZ)(TSX:MDS), today announced the launch of Tempo(TM) Liquid Chromatography (LC) systems, providing integrated front-end solutions for researchers performing LC/MS and LC MALDI-based experiments. High Pressure liquid chromatography (HPLC), a separation step that purifies and resolves compounds in complex matrices, is a staple in life sciences research laboratories, and is often performed prior to mass spectrometry analysis. With the introduction of Tempo(TM) LC systems, Applied Biosystems/MDS SCIEX will offer complete application-based solutions for proteomics, biomarker, and drug discovery studies. These end-to-end systems will provide single-vendor LC/MS solutions that include sales, installation, service, and support.